Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces

Frontiers in Public Health

Mieke Van Den Driessche¹  Greet Vanheule¹  Grégoire Wieërs²  Jean-Christophe Marot²  Valérie Verbelen³  Ekaterina Melnik³  Patrice D. Cani⁴ 

[1] Metagenics Europe, Oostende, Belgium;Service of Internal Medicine, Clinique Saint Pierre, Ottignies-Louvain-la-Neuve, Belgium;Service of Microbiology, Clinique Saint Pierre, Ottignies-Louvain-la-Neuve, Belgium;WELBIO - Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Metabolism and Nutrition Research Group, UCLouvain, Université catholique de Louvain, Brussels, Belgium;

关键词: probiotics;    microbiota;    antibiotic resistance;    prevention;    extended-spectrum beta-lactamase;    AmpC & [beta]-lactamase;    pseudomonas;    clinics and hospitals;   

DOI  :  10.3389/fpubh.2020.578089

来源: Frontiers

【 授权许可】

CC BY